Stockreport

Aerie Pharma's Rhopressa maintains safety profile over six months while matching timolol [Seeking Alpha]

Aerie Pharmaceuticals, Inc.  (AERI) 
Last aerie pharmaceuticals, inc. earnings: 2/20 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.aeriepharma.com/investor-relations
PDF Top-line data from the Phase 3 Rocket 4 study showed Aerie Pharmaceuticals' (NASDAQ: AERI ) Rhopressa (netarsudil ophthalmic solution) maintained its safety char [Read more]